Association of high-density lipoprotein cholesterol with site- specific bone mineral density T-scores in patients with type 2 diabetes aged 50 years or older: a retrospective cross-sectional study
In a retrospective cross-sectional study of 2,568 patients with type 2 diabetes aged 50 or older, higher high-density lipoprotein cholesterol (HDL-C) levels were independently and linearly associated with lower lumbar spine bone mineral density T-scores, an inverse relationship that was particularly pronounced in patients with a lower body mass index.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For decades, doctors have viewed high-density lipoprotein, often called HDL, as the "good" cholesterol. It is the molecule that helps clear fat from the bloodstream, protecting the heart and blood vessels. Because of this reputation, a high level of HDL is usually seen as a sign of good health. At the same time, millions of people live with type 2 diabetes, a condition where the body struggles to manage blood sugar. This disease is known to weaken bones, making them brittle and prone to breaking, a condition known as osteoporosis. For years, scientists have tried to understand how the body's fat metabolism interacts with bone strength, but the answers have been mixed. Some studies suggest that better fat profiles protect bones, while others hint that the relationship might be more complicated, especially in people with diabetes. The question remains: does the same cholesterol that guards the heart also guard the skeleton, or could it be a sign of something else entirely in the context of diabetes?
A team of researchers from hospitals in China set out to investigate this specific puzzle. They looked at the medical records of 2,568 patients, all aged 50 or older, who had been hospitalized for type 2 diabetes. Every single one of these patients had undergone a special scan called a dual-energy X-ray absorptiometry, or DXA, which measures bone density. This scan provides a score, known as a T-score, that tells doctors how strong a person's bones are compared to a healthy young adult. The researchers grouped these patients based on their bone health: those with normal bone density, those with slightly weak bones, and those with osteoporosis. They then compared these groups against the patients' blood test results, paying close attention to their HDL levels, along with other fats and sugars in the blood.
The results turned the traditional view of HDL on its head. The researchers found that among these older adults with diabetes, those with the highest levels of HDL actually had the weakest bones. Specifically, the patients with the lowest bone density scores had the highest HDL numbers. When the team analyzed the data more deeply, adjusting for factors like age, weight, smoking, and the use of medications, the link remained clear. For every increase in HDL levels, the bone density score at the lower back, known as the lumbar spine, went down. This relationship appeared to be straight and steady; as HDL went up, bone strength went down, without any sudden jumps or curves in the pattern. The connection was strongest in the spine, but it was also visible in the hip and other parts of the skeleton.
The study also revealed that body weight played a significant role in this story. The negative link between high HDL and weak bones was much more obvious in patients who were thinner, specifically those with a body mass index below 24. In patients with a higher body weight, the connection was weaker and less clear. This suggests that for thinner individuals with diabetes, high HDL might be a more reliable warning sign of bone loss. The researchers noted that this finding is particularly important because it challenges the idea that high HDL is always a positive sign. In the context of diabetes and bone health, a high HDL level might not mean the body is functioning perfectly; instead, it could be a marker for a specific type of metabolic change that harms the skeleton.
It is important to understand the limits of what this study can tell us. Because the researchers looked at data from a single point in time, they cannot prove that high HDL causes the bones to become weak. It is possible that the underlying disease process of diabetes causes both the high HDL and the bone loss simultaneously. Furthermore, the study focused only on hospitalized patients in one region, so the results might not apply to everyone with diabetes everywhere. The researchers also could not measure the actual function of the HDL particles, only their quantity, leaving open the question of whether the HDL in these patients was working differently than in healthy people. Despite these limitations, the study provides a clear and detailed picture of a surprising association. It suggests that for older adults with type 2 diabetes, doctors should not assume that high HDL is a sign of overall metabolic health without also checking the strength of their bones, especially if the patient is of a lower body weight.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.